Euroopan unioni - suomi - EMA (European Medicines Agency)

daiichi sankyo europe gmbh - quizartinib dihydrochloride - leukemia, myeloidi, akuutti - antineoplastiset aineet - akuutin myelooisen leukemian.

Euroopan unioni - suomi - EMA (European Medicines Agency)

daiichi sankyo europe gmbh - quizartinib dihydrochloride - leukemia, myeloidi - antineoplastic agents, protein kinase inhibitors - vanflyta is indicated in combination with standard cytarabine and anthracycline induction and standard cytarabine consolidation chemotherapy, followed by vanflyta single-agent maintenance therapy for adult patients with newly diagnosed acute myeloid leukaemia (aml) that is flt3-itd positive.

Euroopan unioni - suomi - EMA (European Medicines Agency)

seagen b.v. - tucatinib - breast neoplasms; neoplasm metastasis - antineoplastiset aineet - tukysa is indicated in combination with trastuzumab and capecitabine for the treatment of adult patients with her2‑positive locally advanced or metastatic breast cancer who have received at least 2 prior anti‑her2 treatment regimens.

Euroopan unioni - suomi - EMA (European Medicines Agency)

pfizer europe ma eeig - crizotinib - karsinooma, ei-pienisoluinen keuhko - antineoplastiset aineet - xalkori as monotherapy is indicated for:the first‑line treatment of adults with anaplastic lymphoma kinase (alk)‑positive advanced non‑small cell lung cancer (nsclc)the treatment of adults with previously treated anaplastic lymphoma kinase (alk)‑positive advanced non‑small cell lung cancer (nsclc)the treatment of adults with ros1‑positive advanced non‑small cell lung cancer (nsclc)the treatment of paediatric patients (age ≥6 to.

Suomi - suomi - Fimea (Suomen lääkevirasto)

orion corporation - metformini hydrochloridum - depottabletti - 500 mg - metformiini

Suomi - suomi - Fimea (Suomen lääkevirasto)

orion corporation - metformini hydrochloridum - depottabletti - 750 mg - metformiini

Suomi - suomi - Fimea (Suomen lääkevirasto)

orion corporation - metformini hydrochloridum - depottabletti - 1000 mg - metformiini

Suomi - suomi - Fimea (Suomen lääkevirasto)

mylan ab - imatinib mesylate - tabletti, kalvopäällysteinen - 100 mg - imatinibi

Suomi - suomi - Fimea (Suomen lääkevirasto)

mylan ab - imatinib mesylate - tabletti, kalvopäällysteinen - 400 mg - imatinibi

Suomi - suomi - Fimea (Suomen lääkevirasto)

accord healthcare b.v. - metformin hydrochloride - depottabletti - 500 mg - metformiini